Partially Reversible Immunodeficiency After In-Utero Exposure to Immunosuppressants

被引:0
|
作者
Goessling, Katharina L. [1 ]
Kobbe, Robin [2 ,3 ,4 ]
Boetticher, Benedikt [1 ]
Soura, Stavrieta [1 ]
Borkhardt, Arndt [1 ]
Wittkowski, Helmut [5 ]
Schwab, Matthias [6 ,7 ]
Kobbe, Guido [8 ]
Neubert, Jennifer [1 ]
Ghosh, Sujal [1 ]
Laws, Hans-Juergen [1 ]
Oommen, Prasad Thomas [1 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Med Fac, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Inst Infect Res & Vaccine Dev IIRVD, Hamburg, Germany
[3] Bernhard Nocht Inst Trop Med, Dept Infect Dis Epidemiol, Hamburg, Germany
[4] Bernhard Nocht Inst Trop Med BNITM, Dept Infect Epidemiol, Hamburg, Germany
[5] Univ Childrens Hosp Munster, Dept Pediat Rheumatol & Immunol, Munster, Germany
[6] Dr Margarete F Bosch Inst Clin Pharmacol, Stuttgart, Germany
[7] Univ Hosp Tubingen, Inst Expt & Clin Pharmacol & Toxicol, Tubingen, Germany
[8] Univ Hosp Dusseldorf, Dept Haematol Oncol & Clin Immunol, Dusseldorf, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2023年 / 120卷 / 46期
关键词
D O I
10.3238/arztebl.m2023.0200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Treatment with immunosuppressants affects pregnant women too. The European League Against Rheumatism (EULAR) has published recommendations for action for the use of immuno - suppressants in pregnancy; azathioprine (n=72) and rituximab (n=256) were not associated with increased rates of miscarriage or malformations (1). But long term data on the effects on children's immune reconstitution after exposure to these substances are lacking (2). We report on three cases of exposure to rituximab or azathioprine in utero that led to partly reversible, partly sustained immunodeficiency. © 2023 Deutscher Arzte-Verlag GmbH. All rights reserved.
引用
收藏
页码:795 / 796
页数:2
相关论文
共 50 条
  • [1] NEURODEVELOPMENT AFTER IN-UTERO EXPOSURE TO PHENYTOIN AND CARBAMAZEPINE
    JERET, JS
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (11): : 850 - 850
  • [2] LSD EXPOSURE IN-UTERO
    WARREN, RJ
    RIMOIN, DL
    SLY, WS
    PEDIATRICS, 1970, 45 (03) : 466 - &
  • [3] Premenopausal breast cancer after in-utero exposure to stilboestrol
    Huckell, C
    Laskin, J
    Gelmon, K
    LANCET, 1996, 348 (9023): : 331 - 331
  • [4] Morphology of the male rat gonad after in Utero exposure to immunosuppressants
    Freus, Marika
    Kabat-Koperska, Joanna
    Frulenko, Ignacy
    Wiszniewska, Barbara
    Kolasa, Agnieszka
    REPRODUCTIVE BIOLOGY, 2023, 23 (02)
  • [5] IN-UTERO EXPOSURE TO PHENYTOIN OR CARBAMAZEPINE
    KOREN, G
    CANADIAN FAMILY PHYSICIAN, 1995, 41 : 1862 - 1863
  • [7] IN-UTERO EXPOSURE TO COCAINE - A REVIEW
    ELLIS, JE
    BYRD, LD
    SEXSON, WR
    PATTERSONBARNETT, CA
    SOUTHERN MEDICAL JOURNAL, 1993, 86 (07) : 725 - 731
  • [8] Birth outcomes after in-utero exposure to oral hypoglycaemic drugs
    Chaabane, A
    El Aidli, S
    Kastalli, S
    Ayadi, L
    Daghfous, R
    Lakhal, M
    Loueslati, MH
    Belkahia, C
    DRUG SAFETY, 2005, 28 (10) : 955 - 955
  • [10] Crohn's disease after in-utero measles virus exposure
    Ekbom, A
    Daszak, P
    Kraaz, W
    Wakefield, AJ
    LANCET, 1996, 348 (9026): : 515 - 517